U.S. market Closed. Opens in 16 hours 40 minutes

SMMT | Summit Therapeutics Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312019-01-312018-01-312017-01-312016-01-312015-01-312014-01-312013-01-312012-01-312011-01-312010-01-312009-01-312008-01-312007-01-312006-01-312005-01-312004-01-31
RevenueN/A704.29K1.81M860.00K811.37K56.41M35.98M2.88MN/AN/A2.27M2.87M2.77M1.21M301.94K266.64K6.03M2.03M947.89K212.76K1.82K
Cost of Revenue2.05M2.51MN/AN/A199.50K24.92K97.67KN/AN/AN/AN/AN/AN/AN/AN/A5.76K3.23M596.30K415.93K169.46K1.82K
Gross Profit-2.05M-1.81M1.81M860.00K611.87K56.39M35.88MN/AN/AN/A2.27M2.87MN/AN/AN/A260.87K2.80M1.43M531.96K43.30KN/A
Operating Expenses87.69M64.28M88.00M53.19M53.92M47.69M54.13M33.28M29.45M19.29M13.33M8.51M7.43M-3.98M11.36M15.38M25.35M10.03M3.75M579.92K43.79K
Selling, General & Admin28.21M26.70M23.61M19.23M11.94M16.19M16.98M9.62M7.45M6.80M3.24M2.77M2.31M2.68M4.20M5.03M7.31M1.86M1.79M75.31K43.79K
Research & Development59.47M52.00M85.35M53.27M41.99M51.38M41.01M23.69M23.94M15.64M10.78M5.72M4.78M3.66M3.68M7.38M15.34M5.79M1.83M504.60KN/A
Other Operating Expenses520.91M-14.42M-20.97M-19.31MN/A-19.88M-3.86M-26.25K-1.95M-3.14M-682.90K18.95K339.19K-10.32M3.48M2.97M2.70M2.37M119.60KN/AN/A
Operating Income-89.74M-72.09M-86.19M-53.19M-54.90M12.38M-18.25M-31.07M-29.45M-19.29M-11.07M-5.65M-4.66M5.19M-11.06M-15.11M-22.55M-8.60M-3.21M-536.61K-43.79K
Other Expenses / Income-526.14M-6.69M-2.42M283.00K18.43M-5.78M2.83M-1.07M756.25K213.95K14.85K-1.57M-47.11K-14.55M1.76M-3.77M608.48K1.71M1.04M404.81K1.82K
Before Tax Income-615.87M-78.78M-88.60M-52.91M-36.47M6.60M-15.42M-32.13M-28.69M-19.07M-11.05M-7.21M-4.71M-9.36M-9.30M-18.88M-21.94M-6.88M-2.17M-131.80K-41.96K
Income Tax Expenses-946.00K-4.40M-2.46M-213.00K-5.81M-3.27M-5.32M-5.42M-4.36M-1.95M-1.00M-538.61K-477.37K-1.94M-594.31K-2.52M-1.81M-959.18K-276.69K-45.19KN/A
Net Income-614.93M-74.38M-86.15M-52.70M-30.66M9.87M-10.09M-26.71M-24.34M-17.12M-10.05M-6.67M-4.23M-7.42M-8.66M-32.29M-20.13M-5.92M-1.90M-86.61K-41.96K
Interest Expenses16.46M4.40M281.00K255.00K41.75K556.10K1.65M1.08MN/AN/AN/AN/A4.71K6.33K107.04K116.74K75.56K11.77KN/AN/AN/A
Basic Shares Outstanding619.65M193.34M92.24M69.52M164.15M85.70M65.43M61.55M59.10M8.22M408.93M3.54M187.42M168.27M166.25M53.39M50.84M37.22M31.31M23.46M19.02M
Diluted Shares Outstanding619.65M193.34M92.24M69.52M164.15M86.14M65.43M61.55M59.10M8.22M408.93M3.54M187.42M168.27M166.25M53.39M50.84M37.22M31.31M23.46M19.02M
EBITDA-87.69M-60.80M-86.19M-51.48M-53.11M13.87M-13.42M-30.98M-30.09M-19.38M-11.01M-7.07M-4.41M-8.65M-5.36M-31.95M-18.58M-6.13M-1.93M-122.39K-41.96K
EBITDA Margin0.00%-8,633.17%-4,764.29%-5,985.47%-6,546.15%24.59%-37.31%-1,075.82%0.00%0.00%-485.38%-246.58%-159.04%-715.99%-1,775.66%-11,983.24%-308.42%-302.42%-203.77%-57.52%-2,300.00%
EBIT-599.41M-74.38M-88.32M-52.66M-36.43M7.15M-13.77M-31.06M-28.69M-19.07M-11.05M-7.21M-4.70M-9.36M-9.14M-34.69M-21.86M-6.87M-2.17M-131.80K-41.96K
EBIT Margin0.00%-10,561.06%-4,882.31%-6,122.67%-4,489.71%12.68%-38.27%-1,078.34%0.00%0.00%-487.27%-251.71%-169.69%-774.84%-3,028.57%-13,010.27%-362.87%-338.78%-229.19%-61.95%-2,300.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312019-01-312018-01-312017-01-312016-01-312015-01-312014-01-312013-01-312012-01-312011-01-312010-01-312009-01-312008-01-312007-01-312006-01-312005-01-312004-01-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙